Nab-PTX
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nab-PTX, covering 2020-10-09 to 2021-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer [Phase 1, Phase 2]